Expression of the histone methyltransferase EZH2 in colorectal cancer

被引：0
|
作者：
Carvalho, S. Dias [1 ]
Monteiro-Reis, S. [1 ]
Vieira-Coimbra, M. [1 ]
Pires-Luis, A. [1 ]
Tavares, A. [1 ]
Santos, L. L. [1 ]
Raimundo, A. [1 ]
Jeronimo, C. [1 ]
Henrique, R. [1 ]
机构：
[1] Portuguese Oncol Inst, Oporto, Portugal
来源：
VIRCHOWS ARCHIV | 2016年 / 469卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-01-013
引用
下载
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [41] CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
    Sergey Karakashev
    Hengrui Zhu
    Shuai Wu
    Yuhki Yokoyama
    Benjamin G. Bitler
    Pyoung-Hwa Park
    Jeong-Heon Lee
    Andrew V. Kossenkov
    Krutika Satish Gaonkar
    Huihuang Yan
    Ronny Drapkin
    Jose R. Conejo-Garcia
    David W. Speicher
    Tamas Ordog
    Rugang Zhang
    Nature Communications, 9
  • [42] Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
    Oki, Shinya
    Sone, Kenbun
    Oda, Katsutoshi
    Hamamoto, Ryuji
    Ikemura, Masako
    Maeda, Daichi
    Takeuchi, Makoto
    Tanikawa, Michihiro
    Mori-Uchino, Mayuyo
    Nagasaka, Kazunori
    Miyasaka, Aki
    Kashiyama, Tomoko
    Ikeda, Yuji
    Arimoto, Takahide
    Kuramoto, Hiroyuki
    Wada-Hiraike, Osamu
    Kawana, Kei
    Fukayama, Masashi
    Osuga, Yutaka
    Fujii, Tomoyuki
    ONCOTARGET, 2017, 8 (25) : 40402 - 40411
  • [43] CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
    Karakashev, Sergey
    Zhu, Hengrui
    Wu, Shuai
    Yokoyama, Yuhki
    Bitler, Benjamin G.
    Park, Pyoung-Hwa
    Lee, Jeong-Heon
    Kossenkov, Andrew V.
    Gaonkar, Krutika Satish
    Yan, Huihuang
    Drapkin, Ronny
    Conejo-Garcia, Jose R.
    Speicher, David W.
    Ordog, Tamas
    Zhang, Rugang
    NATURE COMMUNICATIONS, 2018, 9
  • [44] The change of EZH2 expression in development of colorectal cancer from adenoma
    Ohuchi, Mayuko
    Nakamoto, Yasuo
    Tokunaga, Ryuma
    Nakamura, Kenichi
    Kosumi, Keisuke
    Harada, Kazuto
    Shigaki, Hironobu
    Kurashige, Junji
    Iwatsuki, Masaaki
    Baba, Yoshifumi
    Miyamoto, Yuji
    Yoshida, Naoya
    Baba, Hideo
    CANCER RESEARCH, 2016, 76
  • [45] Histone methyltransferase EZH2 epigenetically affects CCNA1 expression in acute myeloid leukemia
    Yang, Xiaoyang
    Wan, Mengjie
    Yu, Feng
    Wu, Xiuji
    CELLULAR SIGNALLING, 2021, 87
  • [46] HISTONE METHYLTRANSFERASE EZH2 IS CRITICAL FOR HSD11B2 EXPRESSION IN HUMAN TROPHOBLAST CELLS
    Zuo, Rujuan
    Liu, Xiaohui
    Lu, Yi
    Li, Wenjiao
    Sun, Kang
    PLACENTA, 2016, 45 : 101 - 101
  • [47] The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors
    Svedlund, Jessica
    Barazeghi, Elham
    Stalberg, Peter
    Hellman, Per
    Akerstrom, Goran
    Bjorklund, Peyman
    Westin, Gunnar
    ENDOCRINE-RELATED CANCER, 2014, 21 (02) : 231 - 239
  • [48] Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation
    Jie Zhou
    Shuo Huang
    Zhongyu Wang
    Jiani Huang
    Liang Xu
    Xuefeng Tang
    Yisong Y. Wan
    Qi-jing Li
    Alistair L. J. Symonds
    Haixia Long
    Bo Zhu
    Nature Communications, 10
  • [49] Activated p53 suppresses the histone methyltransferase EZH2 gene
    Tang, XH
    Milyavsky, M
    Shats, I
    Erez, N
    Goldfinger, N
    Rotter, V
    ONCOGENE, 2004, 23 (34) : 5759 - 5769
  • [50] The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
    Zingg, Daniel
    Arenas-Ramirez, Natalia
    Sahin, Dilara
    Rosalia, Rodney A.
    Antunes, Ana T.
    Haeusel, Jessica
    Sommer, Lukas
    Boyman, Onur
    CELL REPORTS, 2017, 20 (04): : 854 - 867
12345